Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

T Ruff

Showing results (121-130 of 224) with videos related to

Pageof 23
Sort By:
Chest|August 26, 2018
Antithrombotic Therapy for Atrial Fibrillation: CHEST Guideline and Expert Panel ReportGregory Y H Lip, Amitava Banerjee, Giuseppe Boriani, et al.
American Heart Journal|February 10, 2016
Edoxaban vs warfarin in patients with nonvalvular atrial fibrillation in the US Food and Drug Administration approval population: An analysis from the Effective Anticoagulation with Factor Xa Next Generation in Atrial Fibrillation-Thrombolysis in Myocardial Infarction 48 (ENGAGE AF-TIMI 48) trialAlon Eisen, Robert P Giugliano, Christian T Ruff, et al.
European Journal of Heart Failure|March 29, 2023
Serial assessment of biomarkers and heart failure outcomes in patients with atrial fibrillationKazuma Oyama, Robert P Giugliano, Christian T Ruff, et al.
International Journal of Cardiology|December 11, 2013
Long-term cardiovascular outcomes in patients with atrial fibrillation and atherothrombosis in the REACH RegistryChristian T Ruff, Deepak L Bhatt, Ph Gabriel Steg, et al.
Journal of the American Heart Association|January 10, 2025
Epistaxis Versus Nonepistaxis Bleeding in Anticoagulated Patients With Atrial Fibrillation: Results From the ENGAGE AF-TIMI 48 TrialRobert S Semco, Regan W Bergmark, Sabina A Murphy, et al.
Diabetes, Obesity & Metabolism|December 19, 2024
Type 2 diabetes genetic risk and incident diabetes across diabetes risk enhancersFilipe A Moura, Frederick K Kamanu, Stephen D Wiviott, et al.
International Journal of Cardiology|November 25, 2010
Safety and efficacy of prasugrel compared with clopidogrel in different regions of the worldChristian T Ruff, Robert P Giugliano, Elliott M Antman, et al.
Journal of the American Heart Association|July 13, 2016
Sudden Cardiac Death in Patients With Atrial Fibrillation: Insights From the ENGAGE AF-TIMI 48 TrialAlon Eisen, Christian T Ruff, Eugene Braunwald, et al.
European Journal of Heart Failure|November 29, 2019
Left atrial structure and function and the risk of death or heart failure in atrial fibrillationRiccardo M Inciardi, Robert P Giugliano, Brian Claggett, et al.
Journal of the American College of Cardiology|August 9, 2014
Transition of patients from blinded study drug to open-label anticoagulation: the ENGAGE AF-TIMI 48 trialChristian T Ruff, Robert P Giugliano, Eugene Braunwald, et al.
Pageof 23

Showing results (121-130 of 224) with videos related to

Sort By:
Pageof 23
Chest|August 26, 2018
Antithrombotic Therapy for Atrial Fibrillation: CHEST Guideline and Expert Panel ReportGregory Y H Lip, Amitava Banerjee, Giuseppe Boriani, et al.
American Heart Journal|February 10, 2016
Edoxaban vs warfarin in patients with nonvalvular atrial fibrillation in the US Food and Drug Administration approval population: An analysis from the Effective Anticoagulation with Factor Xa Next Generation in Atrial Fibrillation-Thrombolysis in Myocardial Infarction 48 (ENGAGE AF-TIMI 48) trialAlon Eisen, Robert P Giugliano, Christian T Ruff, et al.
European Journal of Heart Failure|March 29, 2023
Serial assessment of biomarkers and heart failure outcomes in patients with atrial fibrillationKazuma Oyama, Robert P Giugliano, Christian T Ruff, et al.
International Journal of Cardiology|December 11, 2013
Long-term cardiovascular outcomes in patients with atrial fibrillation and atherothrombosis in the REACH RegistryChristian T Ruff, Deepak L Bhatt, Ph Gabriel Steg, et al.
Journal of the American Heart Association|January 10, 2025
Epistaxis Versus Nonepistaxis Bleeding in Anticoagulated Patients With Atrial Fibrillation: Results From the ENGAGE AF-TIMI 48 TrialRobert S Semco, Regan W Bergmark, Sabina A Murphy, et al.
Diabetes, Obesity & Metabolism|December 19, 2024
Type 2 diabetes genetic risk and incident diabetes across diabetes risk enhancersFilipe A Moura, Frederick K Kamanu, Stephen D Wiviott, et al.
International Journal of Cardiology|November 25, 2010
Safety and efficacy of prasugrel compared with clopidogrel in different regions of the worldChristian T Ruff, Robert P Giugliano, Elliott M Antman, et al.
Journal of the American Heart Association|July 13, 2016
Sudden Cardiac Death in Patients With Atrial Fibrillation: Insights From the ENGAGE AF-TIMI 48 TrialAlon Eisen, Christian T Ruff, Eugene Braunwald, et al.
European Journal of Heart Failure|November 29, 2019
Left atrial structure and function and the risk of death or heart failure in atrial fibrillationRiccardo M Inciardi, Robert P Giugliano, Brian Claggett, et al.
Journal of the American College of Cardiology|August 9, 2014
Transition of patients from blinded study drug to open-label anticoagulation: the ENGAGE AF-TIMI 48 trialChristian T Ruff, Robert P Giugliano, Eugene Braunwald, et al.
Pageof 23